Data / Drug companies / Haleon US Holdings LLC
Haleon US Holdings LLC: 78 products in the FDA NDC directory, labeler code 0067
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Haleon US Holdings LLC (labeler code 0067) lists 78 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 77 over the counter drugs, 1 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 31, 2026.
The request: Watch Haleon US Holdings LLC (FDA labeler code 0067): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0067
- Products in commercial distribution
- 78
- Packages
- 168
- Finished drugs by generic name
- 23
- Prescription products
- 0
- Over the counter products
- 77
- Flagged as original packager
- 77 of 77 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- September 27, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 69 | 88.5% |
| New drug applications (NDA) | 8 | 10.3% |
| Drugs for further processing | 1 | 1.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 77 | 98.7% |
| Drugs for further processing | 1 | 1.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen, diphenhydramine hcl, phenylephrine hcl | 6 | 7 |
| Acetaminophen, dextromethorphan hbr | 6 | 20 |
| Simethicone | 6 | 86 |
| Acetaminophen, dextromethorphan hbr, phenylephrine hcl | 5 | 45 |
| Acetaminophen, aspirin (nsaid), and caffeine | 5 | 2 |
| Sennosides | 3 | 65 |
| Acetaminophen, aspirin (nsaid), caffeine | 3 | 4 |
| Acetaminophen, diphenhydramine hcl | 3 | 42 |
| Diclofenac sodium | 3 | 109 |
| Oxymetazoline hcl | 2 | 15 |
| Acetaminophen, asprin, caffeine | 2 | 1 |
| Calcium carbonate, simethicone | 2 | 4 |
| Acetaminophen, dextromethorphan hbr, diphenhydramine hcl | 2 | 5 |
| Acetaminophen, dextromethorphan, phenylephrine | 2 | 3 |
| Acetaminophen, aspirin (nsaid) and caffeine | 2 | 2 |
| Acetaminophen, dextromethorphan hbr, pseudoephedrine hcl | 1 | 1 |
| Acetaminophen | 1 | 214 |
| Sennosides, stimulant laxative | 1 | 1 |
| Acetaminophen, dextromethorphan hbr, guaifenesin | 1 | 3 |
| Acetaminophen, aspirin, and caffeine | 1 | 13 |
| Acetaminophen, caffeine | 1 | 14 |
| Acetaminophen, aspirin (nsaid) and diphenhydramine citrate | 1 | 1 |
| Phenylephrine hydrochloride | 1 | 77 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 15 | 19.2% |
| Tablet, film coated | 14 | 17.9% |
| Powder, for solution | 13 | 16.7% |
| Syrup | 9 | 11.5% |
| Tablet, chewable | 7 | 9% |
| Powder | 4 | 5.1% |
| Tablet, coated | 4 | 5.1% |
| Capsule, liquid filled | 4 | 5.1% |
| Tablet | 3 | 3.8% |
| Spray | 3 | 3.8% |
| Pill | 1 | 1.3% |
| Gel | 1 | 1.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Excedrin Rapid Relief | 0067-2200 | Tablet | Over the counter monograph drugs | March 31, 2026 |
| Gas-X Ultimate Strength Softgels | 0067-8075 | Capsule, liquid filled | Over the counter monograph drugs | June 13, 2025 |
| Theraflu Severe Congestion Relief Nasal Mist | 0067-0110 | Spray | Over the counter monograph drugs | June 1, 2025 |
| Theraflu Severe Congestion Relief Cooling Nasal Mist | 0067-0109 | Spray | Over the counter monograph drugs | June 1, 2025 |
| Voltaren Arthritis Pain | 0067-8154 | Kit | New drug applications (NDA) | February 19, 2025 |
| Theraflu Severe Cold Relief Nighttime Soft Chews | 0067-0112 | Tablet, chewable | Over the counter monograph drugs | September 30, 2024 |
| Theraflu-D Flu Relief Max Strength plus Nasal Decongestant | 0067-0115 | Syrup | Over the counter monograph drugs | June 19, 2024 |
| Theraflu-D Flu Relief Max Strength plus Nasal Decongestant Nighttime | 0067-0114 | Syrup | Over the counter monograph drugs | June 19, 2024 |
| Theraflu Severe Cold Relief Soft Chews | 0067-0111 | Tablet, chewable | Over the counter monograph drugs | June 19, 2024 |
| Theraflu Severe Cold Relief Combo Pack | 0067-0123 | Kit | Over the counter monograph drugs | June 1, 2024 |
| Theraflu Severe Cold Relief Combo Pack | 0067-0122 | Kit | Over the counter monograph drugs | April 15, 2024 |
| Theraflu Severe Cold Relief | 0067-0107 | Kit | Over the counter monograph drugs | February 1, 2024 |
| Acetaminophen, aspirin, caffeine | 0067-4202 | Tablet, film coated | Drugs for further processing | January 1, 2024 |
| Excedrin Migraine Relief | 0067-2042 | Tablet, film coated | New drug applications (NDA) | January 1, 2024 |
| Excedrin Extra Strength Headache | 0067-2003 | Tablet, film coated | Over the counter monograph drugs | January 1, 2024 |
| Excedrin Extra Strength Headache | 0067-2002 | Tablet, film coated | Over the counter monograph drugs | January 1, 2024 |
| Theraflu Severe Cold Relief Daytime Berry Burst | 0067-0106 | Powder, for solution | Over the counter monograph drugs | December 1, 2023 |
| Theraflu Severe Cold Relief Nighttime | 0067-0105 | Syrup | Over the counter monograph drugs | December 1, 2023 |
| Theraflu Severe Cold Relief Chest Congestion Daytime | 0067-0104 | Syrup | Over the counter monograph drugs | December 1, 2023 |
| Theraflu Severe Cold Relief Daytime Honey Ginger | 0067-0103 | Powder, for solution | Over the counter monograph drugs | December 1, 2023 |
| Theraflu Severe Cold Relief Nighttime | 0067-0101 | Powder, for solution | Over the counter monograph drugs | December 1, 2023 |
| Theraflu Severe Cold Relief Daytime | 0067-0100 | Powder, for solution | Over the counter monograph drugs | December 1, 2023 |
| Theraflu Severe Cold Relief Nighttime with Honey Elderberry Flavor | 0067-8212 | Powder, for solution | Over the counter monograph drugs | May 1, 2023 |
| Theraflu Severe Cold Relief Daytime with Honey Ginger Flavor | 0067-8211 | Powder, for solution | Over the counter monograph drugs | May 1, 2023 |
| Theraflu Severe Cold Relief Daytime and Theraflu Severe Cold Relief Nighttime | 0067-6804 | Kit | Over the counter monograph drugs | January 20, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.